Healthcare -
Biotechnology - NASDAQ - US
$ 42.365
-1.29 %
$ 3.92 B
Market Cap
-6.74
P/E
RARE - NET INCOME
Net Income RARE - Ultragenyx Pharmaceutical Inc.
-569 M
LAST VALUE
10.30%
2 YEAR CAGR
-7.16%
5 YEAR CAGR
-25.27%
10 YEAR CAGR